Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor

被引：0
|
作者：
Rink, Lori
Skorobogatko, Yuliya
Kossenkov, Andrew
Belinsky, Martin
Pajak, Thomas
von Mehren, Margaret
Ochs, Michael
Eisenberg, Burton
Godwin, Andrew
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA
[4] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3844
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor
    Rink, Lori
    Skorobogatko, Yuliya
    Kossenkov, Andrew V.
    Belinsky, Martin G.
    Pajak, Thomas
    Heinrich, Michael C.
    Blanke, Charles D.
    von Mehren, Margaret
    Ochs, Michael F.
    Eisenberg, Burton
    Godwin, Andrew K.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (08) : 2172 - 2182
  • [2] Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
    Bauer, S
    Corless, CL
    Heinrich, MC
    Dirsch, O
    Antoch, G
    Kanja, J
    Seeber, S
    Schütte, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) : 261 - 265
  • [3] Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT
    Sebastian Bauer
    Christopher L. Corless
    Michael C. Heinrich
    Olaf Dirsch
    Gerald Antoch
    Jörg Kanja
    Siegfried Seeber
    Jochen Schütte
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 261 - 265
  • [4] Imatinib mesylate for the treatment of gastrointestinal stromal tumor
    Cassier, Philippe A.
    Blay, Jean-Yves
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (05) : 623 - 634
  • [5] Giant Gastrointestinal Stromal Tumor with Remarkable Preoperative Response to Imatinib Mesylate
    Stokes, Allen
    Herndon, Mark D.
    Conforti, Arnold M.
    AMERICAN SURGEON, 2010, 76 (08) : 903 - 904
  • [6] Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor
    Quezada, Nicolas
    Acevedo, Francisco
    Marambio, Andres
    Leon, Felipe
    Galindo, Hector
    Roa, Juan Carlos
    Jarufe, Nicolas
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2014, 5 (10): : 681 - 685
  • [7] Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor
    Trent, Jonathan C.
    Dupart, Jheri
    Zhang, Wei
    CURRENT CANCER THERAPY REVIEWS, 2005, 1 (01) : 93 - 108
  • [8] Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate
    Ryu, MH
    Lee, JL
    Chang, HM
    Kim, TW
    Kang, HJ
    Sohn, HJ
    Lee, JS
    Kang, YK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 17 - 24
  • [9] A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor
    Ben Ami, Eytan
    Demetri, George D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 571 - 578
  • [10] Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate
    Kun-Chun Chiang
    Tsung-Wen Chen
    Chun-Nan Yeh
    Hsiang-Lin Lee
    World Journal of Gastroenterology, 2006, (13) : 2060 - 2064
12345